00000000nam 2200000zi 4500
0019.947789
003CaOODSP
00520250428091713
006m     o  d f      
007cr mn|||||||||
008250206e20250313onc     ob   f000 0 eng d
020 |a9780660756226 |q(statement)
020 |a9780660756233 |q(summary)
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP40-384/2025E-PDF
0861 |aHP40-384/2025-1E-PDF
24500|aUpdated guidance on respiratory syncytial virus (RSV) vaccines for older adults including the expanded use of RSVPreF3 for individuals 50-59 years of age and use of the new mRNA-1345 vaccine.
264 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cMarch 13, 2025.
264 4|c©2025
300 |a1 online resource (51 pages) + |esummary (5 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Directives mises à jour sur les vaccins contre le virus respiratoire syncytial (VRS) chez les personnes âgées, y compris l'utilisation élargie du VRSPreF3 chez les individus de 50 à 59 ans et l'utilisation du nouveau vaccin ARNm-1345.
500 |aOn cover: An advisory committee statement (ACS), National Advisory Committee on Immunization (NACI).
500 |a"Pub.: 240852"--Page 2.
500 |a"Pub.: 240854"--Page 2 (summary).
504 |aIncludes bibliographical references (pages 47-51).
650 0|aRespiratory syncytial virus|xVaccination|xGovernment policy|zCanada.
650 0|aViral vaccines|xGovernment policy|zCanada.
650 0|aImmunization of older people|xGovernment policy|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
7101 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body.
77508|tDirectives mises à jour sur les vaccins contre le virus respiratoire syncytial (VRS) chez les personnes âgées, y compris l'utilisation élargie du VRSPreF3 chez les individus de 50 à 59 ans et l'utilisation du nouveau vaccin ARNm-1345.|w(CaOODSP)9.947790
85640|qPDF|s871 KB|uhttps://publications.gc.ca/collections/collection_2025/aspc-phac/HP40-384-2025-eng.pdf|z(statement)
85640|qPDF|s222 KB|uhttps://publications.gc.ca/collections/collection_2025/aspc-phac/HP40-384-2025-1-eng.pdf|z(summary)
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-statement-updated-guidance-rsv-vaccines-older-adults-including-expanded-use-rsvpref3-individuals-50-59-years-age-use-new-mrna-1345-vaccine.html|z(statement)
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-summary-updated-guidance-rsv-vaccines-older-adults-including-expanded-use-rsvpref3-individuals-50-59-years-age-use-new-mrna-1345-vaccine.html|z(summary)